Kristin Blom
PhD student at Department of Medical Sciences; Cancer Pharmacology and Computational Medicine
- Telephone:
- +46 18 611 10 10
- E-mail:
- Kristin.Blom@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, Ing 61, 4 tr
SE-751 85 Uppsala
Sweden - Postal address:
- Akademiska sjukhuset, Ing 61, 4 tr
SE-751 85 Uppsala
Sweden
Publications
Recent publications
-
Part of Oncology Reports, 2026
- DOI for Characterization of the anticancer effect of mebendazole and its interaction with standard cytotoxic drugs in patient tumor cells ex vivo and in an in vivo mouse model
- Download full text (pdf) of Characterization of the anticancer effect of mebendazole and its interaction with standard cytotoxic drugs in patient tumor cells ex vivo and in an in vivo mouse model
-
Ex vivo drug responses and molecular profiles of 597 pediatric acute lymphoblastic leukemia patients
Part of HemaSphere, 2025
- DOI for Ex vivo drug responses and molecular profiles of 597 pediatric acute lymphoblastic leukemia patients
- Download full text (pdf) of Ex vivo drug responses and molecular profiles of 597 pediatric acute lymphoblastic leukemia patients
-
OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids
Part of Scientific Reports, 2024
- DOI for OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids
- Download full text (pdf) of OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids
-
Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening
Part of NAR Genomics and Bioinformatics, 2024
- DOI for Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening
- Download full text (pdf) of Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening
-
Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
Part of British Journal of Surgery, p. 1080-1083, 2023
- DOI for Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
- Download full text (pdf) of Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
All publications
Articles in journal
-
Part of Oncology Reports, 2026
- DOI for Characterization of the anticancer effect of mebendazole and its interaction with standard cytotoxic drugs in patient tumor cells ex vivo and in an in vivo mouse model
- Download full text (pdf) of Characterization of the anticancer effect of mebendazole and its interaction with standard cytotoxic drugs in patient tumor cells ex vivo and in an in vivo mouse model
-
Ex vivo drug responses and molecular profiles of 597 pediatric acute lymphoblastic leukemia patients
Part of HemaSphere, 2025
- DOI for Ex vivo drug responses and molecular profiles of 597 pediatric acute lymphoblastic leukemia patients
- Download full text (pdf) of Ex vivo drug responses and molecular profiles of 597 pediatric acute lymphoblastic leukemia patients
-
OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids
Part of Scientific Reports, 2024
- DOI for OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids
- Download full text (pdf) of OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids
-
Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening
Part of NAR Genomics and Bioinformatics, 2024
- DOI for Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening
- Download full text (pdf) of Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening
-
Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
Part of British Journal of Surgery, p. 1080-1083, 2023
- DOI for Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
- Download full text (pdf) of Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases
-
Part of Anti-Cancer Drugs, p. 92-102, 2023
- DOI for Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients
- Download full text (pdf) of Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients
-
Part of International Journal of Oncology, 2022
- DOI for Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome
- Download full text (pdf) of Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome
-
Part of Scientific Reports, 2022
- DOI for Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma
- Download full text (pdf) of Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma
-
Conditions for maintenance of hepatocyte differentiation and function in 3D cultures
Part of iScience, 2021
- DOI for Conditions for maintenance of hepatocyte differentiation and function in 3D cultures
- Download full text (pdf) of Conditions for maintenance of hepatocyte differentiation and function in 3D cultures
-
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
Part of Scientific Reports, 2020
- DOI for Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
- Download full text (pdf) of Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
-
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
Part of BMC Research Notes, 2019
- DOI for Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
- Download full text (pdf) of Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
-
Part of Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), p. 85-91, 2018
-
Targeting tumor cells based on Phosphodiesterase 3A expression
Part of Experimental Cell Research, p. 308-315, 2017
-
Part of Immunopharmacology and immunotoxicology, p. 199-210, 2017
-
Part of SLAS TECHNOLOGY, p. 306-314, 2017
-
Part of Biochemical Pharmacology, p. 40-49, 2016
-
Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy
Part of JALA, p. 178-187, 2016
-
The production of the eosinophil proteins ECP and EPX/EDN are regulated in a reciprocal manner
Part of Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), p. 283-291, 2014
-
Part of World Journal of Gastroenterology, p. 6409-6419, 2012